Medication for depression is nothing new. Tofranil (imipramine), the first drug designed specifically to treat depression, was released in the late 1950s. Tofranil fundamentally changed the way depression was treated and understood by the medical community and the public alike. Hailed as a “miracle cure,” it quickly gained dozens of tricyclic rivals as pharmaceutical companies sought to stake out their place in the market. While the drugs were effective, helping 60-80% of patients find relief from symptoms, they also had serious drawbacks—weight gain, lethargy, and even risk of overdose. In other words, there was plenty of room for improvement.
That improvement came in the late 1980s in the form of a new class of antidepressants: SSRIs. Prozac became the first FDA approved SSRI in 1987 and by the next year, 2,469,000 Prozac prescriptions had been dispensed in the United States. Four years later, Elizabeth Wurtzel would tell millions of Prozac Nation readers about how this new generation of miracle drugs changed her life. Before being medicated, she was suicidal and felt she was living in “a computer program of total negativity … an absence of affect, absence of feeling, absence of response, absence of interest.” That changed when she began taking Prozac. “One morning I woke up and really did want to live … It was as if the miasma of depression had lifted off me, in the same way that the fog in San Francisco rises as the day wears on. Was it the Prozac? No doubt.” Her book raised the profile of Prozac like no drug advertisement ever could, and by 2002, the number of Prozac prescriptions written each year totaled over 33 million. Today, antidepressants are the second most commonly prescribed medication type in America, taken by 13% of the population.
Prozac, of course, isn’t alone—there is Zoloft, Paxil, Lexapro, Celexa. There are also new antidepressant types, offering options for people who didn’t respond to SSRIs. And, of course, there are other medications that are not antidepressants but can be used to treat depression or augment antidepressant treatment. And while this plethora of medication options has undoubtedly opened up avenues for healing for countless people struggling with major depression, it also reflects a widespread belief that medication can be the central—and often, only—focus in depression treatment. But empirical data does not support this conclusion. Rather, antidepressant treatment must be coupled with psychotherapeutic approaches that help you develop meaningful coping skills in order to achieve true recovery from major depression.


